NAD+
Often positioned around cellular energy, mitochondrial support, and overall well-being, with literature exploring neuroprotection and fatigue-related pathways.
View medication pageTherapy Hub
Pain & Wellness
Pain and wellness categories often bring together therapies used to support energy, stress resilience, and overall well-being alongside broader treatment plans. The medications listed here are included because the supporting literature often discusses mitochondrial energy biology, neuroprotection, or stress-related symptom modulation, though the strength of evidence varies by indication.
Available Medications
Each medication below is grouped here because its mechanism, clinical use, or published literature helps explain why it fits this therapy category.
Oxytocin
Studied for effects on anxiety, stress regulation, PTSD-related symptoms, and broader well-being, though responses are context-dependent.
View medication pageMore Medications Available
This is not a comprehensive list of our available medications. We have what you need.
Contact us for moreReferences
Studies, data, and supporting evidence
These references support the positioning statements used on this therapy hub. They are intended as educational source material for patients and prescribers, not as a substitute for individualized medical judgment.
NAD+ in Brain Aging and Neurodegenerative Disorders
Review describing how raising NAD+ can improve mitochondrial bioenergetics and neuronal survival, supporting its wellness and neuroprotection positioning.
Full Text →Evaluation of Safety and Effectiveness of NAD in Different Clinical Applications
Systematic review summarizing human work on NAD+/NADH and emphasizing its central role in oxidative phosphorylation, ATP production, and DNA repair, while noting evidence is still uneven across clinical endpoints.
PubMed →Preventing PTSD with Oxytocin
Randomized study suggesting repeated intranasal oxytocin may be promising as an early preventive intervention in individuals at high risk for PTSD.
Full Text →Augmenting Prolonged Exposure Therapy for PTSD with Intranasal Oxytocin
Trial data showing lower PTSD symptom severity early in treatment with oxytocin augmentation, supporting its placement in stress and wellness discussions while still remaining investigational.
Full Text →Evidence strength is not identical across all therapies. Some placements are supported by FDA labeling or landmark randomized trials, while others rely more heavily on mechanistic, adjunctive, or early-stage literature and should be framed accordingly.